Astellas and its affiliates globally are fully committed to increased transparency within the pharmaceutical industry and to strengthening the public trust in the relationships between pharmaceutical companies, healthcare professionals (HCPs) and healthcare organizations (HCOs).

Astellas will publicly disclose all transfers of value (ToVs) and/or collaborations with HCPs and will make any disclosure of such to relevant governmental bodies and/or industry associations in accordance with the transparency rules applicable to the country of HCPs’ principal place of practice which may include national legal or regulatory requirements, requirements from regional Codes of Practice for the pharmaceutical industry and/or from applicable local industry codes (Applicable Rules).

For countries that are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA), further information on the Applicable Rules is available on the EFPIA’s Transparency website and on the websites of EFPIA relevant member associations from your country of residence. List of EFPIA member associations is available on https://www.efpia.eu/about-us/membership/.

For each country where Astellas has an obligation to disclose ToV, such disclosures will typically include the following (if relevant): (a) personal identifiers such as names and surnames and personal contact details of the HCPs concerned; (b) the scope of such disclosures (i.e. the type of individuals covered as well as the type of ToVs disclosed); (c) the legal basis of the underlying processing of personal data for such disclosures; (d) the country of disclosure; (e) the currency; (f) the timing; (g) the calculation of amounts disclosed.

Such disclosures of transfers of value and the associated processing of personal data will typically take place in accordance with one of the following legal bases, depending on which one of them applies in the HCP’s principal place of practice:

  • the prior consent of the HCP;
  • a legal requirement to provide such mandatory disclosures;
  • Astellas’ legitimate interest to establish transparent relationships with healthcare professionals.

The second column in the table below specifies which one of the above legal bases applies in the country of a given HCP’s principal place of practice.

For countries that are members of EFPIA, information relating to ToV that Astellas has made to HCPs will be made publicly available for a minimum period of 3 years from the date of its publication, unless otherwise required by the Applicable Rules. Astellas will retain the information for a minimum of 5 years after the end of the calendar year to which the disclosure relates.

HCPs can exercise their data protection rights at any time including, where applicable, withdrawing any consent granted or objecting to any further processing by clicking here. If consent is withdrawn, personal information will be removed from the publication on Astellas’ webpage and/or other platforms as soon as reasonably practicable from the date such decision is communicated to Astellas.

Further information about how Astellas processes the personal information of HCPs is also available in Astellas HCP Privacy Notice.

 

Country Legal basis for disclosures of ToVs and/or collaboration with HCPs
Australia

Australia

Mandatory due to legal requirements
Austria

Austria 

Consent
Belgium

Belgium

Mandatory due to legal requirements
Bosnia & Herzegovina

Bosnia & Herzegovina

Consent
Brazil

Brazil

Mandatory due to legal requirements in one state
Bulgaria

Bulgaria

Consent
Chile

Chile

Consent
Colombia

 Colombia

Consent
Croatia

Croatia

Consent
Cyprus

Cyprus

Consent
Czech Republic

Czech Republic

Consent
Denmark

Denmark

Mandatory due to legal requirements
Estonia

Estonia*

Mandatory due to legal requirements
Finland

Finland

Consent
France

France

Mandatory due to legal requirements
Germany

Germany

Consent
Greece

Greece

Consent
Hungary

Hungary

Consent
Iceland

Iceland

Consent
Indonesia

Indonesia

Mandatory due to legal requirements 

Ireland

Ireland

Legitimate Interest
Israel

Israel

Mandatory due to legal requirements
Italy

Italy

Consent
Japan

Japan

Mandatory due to legal requirements
Latvia

Latvia*

Mandatory due to legal requirements
Lithuania

Lithuania*

Mandatory due to legal requirements
Luxembourg

Luxembourg

Consent
Malta

Malta

Consent
Mexico

Mexico

Consent
Netherlands

Netherlands

Mandatory due to legal requirements
North Macedonia

North Macedonia

Consent
Norway

Norway

Legitimate Interest
Philippines

Philippines

Mandatory due to legal requirements
Poland

Poland

Consent
Portugal

Portugal

Mandatory due to legal requirements
Romania

Romania

Mandatory due to legal requirements
Serbia

Serbia

Consent
Slovakia

Slovakia

Mandatory due to legal requirements
Slovenia

Slovenia

Consent
South Korea

South Korea

Mandatory due to legal requirements
Spain

Spain

Legitimate Interest
Sweden

Sweden

Consent
Switzerland

Switzerland

Consent
Turkey

Turkey

Consent
U.K.

U.K.

Legitimate Interest
Ukraine

Ukraine

Consent
USA

USA

Mandatory due to legal requirements